PSYLO-3002

N/A

Report date: 2025/01/26 18:38:23
NME

Base Information

Drug NamePSYLO-3002
Drug Alias NamePSYLO-3002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor modulatorsSerotonin 2c (5-HT2c) receptor modulators
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsSubstance-Related DisordersObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXylo Bio
China Registration ClassN/A

Develop Information

Active CompaniesXylo BioDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsSubstance-Related DisordersObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A